Tauroursodeoxycholate reduces ischemic damage in human allografts: A biochemical and ultrastructural study

被引：8

作者：

Falasca, L

Tisone, G

Orlando, G

Baiocchi, L

Vennerecci, G

Anselmo, A

Torri, E

Di Paolo, D

Strati, F

Casciani, CU

Angelico, M

机构：

[1] Univ Roma Tor Vergata, Dept Surg, Liver Tranplantat Ctr, Rome, Italy

[2] Univ Roma Tor Vergata, Div Gastroenterol & Pathol, Rome, Italy

来源：

TRANSPLANTATION PROCEEDINGS | 2000年 / 32卷 / 01期

关键词：

D O I：

10.1016/S0041-1345(99)00872-6

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 [免疫学];

摘要：

[No abstract available]

引用

页码：49 / 50

页数：2

共 4 条

[1]

HERTL M, 1997, HEPATOLOGY, V26

[2]

Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis [J].

Setchell, KDR ;

Rodrigues, CMP ;

Podda, M ;

Crosignani, A .

GUT, 1996, 38 (03) :439-446

[3]

STRASBERG RM, 1997, LIVER TRANSPL SUR S1, V3, pS1

[4]

SELECTING THE DONOR LIVER - RISK-FACTORS FOR POOR FUNCTION AFTER ORTHOTOPIC LIVER-TRANSPLANTATION [J].

STRASBERG, SM ;

HOWARD, TK ;

MOLMENTI, EP ;

HERTL, M .

HEPATOLOGY, 1994, 20 (04) :829-838

← 1 →